Recombinant Human BCL2L14 Protein ，GST

BCL2L14, also known as BH3-only protein, is a member of the BCL-2 protein family, which plays a critical role in the regulation of apoptosis and cell survival. The BCL-2 family proteins are crucial in the intrinsic pathway of apoptosis, with BH3-only proteins acting as pro-apoptotic factors that initiate cell death in response to various stressors. The emerging role of BCL2L14 in cancer biology has garnered attention, as its expression levels have been correlated with tumor progression and response to therapy in various cancers. Previous studies suggest that BCL2L14 may function as a tumor suppressor by enhancing apoptosis in response to oncogenic signals, thereby inhibiting tumor cell proliferation. Additionally, the modulation of BCL2L14 activity has been linked to resistance to chemotherapy, making it a potential therapeutic target for enhancing the efficacy of cancer treatments. Understanding the functional mechanisms of BCL2L14 at the molecular level, including its interactions with other BCL-2 family members and associated signaling pathways, is critical for developing novel therapeutic strategies aimed at manipulating cell survival in cancer and other diseases. Hence, research on recombinant BCL2L14 protein not only provides insights into its biological functions but also paves the way for potential interventions that could leverage its pro-apoptotic properties in clinical applications, offering hope for improving patient outcomes in oncology.